Bristol-Myers Squibb (BMY) Stock Analysis
Bristol-Myers Squibb trades on the NYSE under the ticker BMY. StonkBuddy files it under Healthcare. It is in the S&P 500.
BMY price context
- 52-week range: $42.52 to $68.64 (as of October 23, 2026)
- Market value: about $120.17 billion (October 19, 2026)
Next earnings
Bristol-Myers Squibb is expected to report results on October 29, 2026, before the market opens. Earnings calendar
Congress trades in BMY
In the last 12 months, members of Congress reported 6 trades in BMY (House and Senate disclosure reports). The latest reported:
- Mike Kelly: Sold, $15,001 - $50,000, traded May 7, 2026, reported June 11, 2026 (filing)
- Alan Armstrong: Bought, $1,001 - $15,000, traded March 27, 2026, reported July 21, 2026 (filing)
- Gilbert Ray Cisneros, Jr.: Bought, $1,001 - $15,000, traded December 19, 2025, reported January 12, 2026 (filing)
- Julie Johnson: Sold, $1,001 - $15,000, traded December 18, 2025, reported January 15, 2026 (filing)
- Julie Johnson: Sold part, $1,001 - $15,000, traded November 13, 2025, reported December 11, 2025 (filing)
All Congress trades · Filed this week
Members also see the StonkBuddy score for BMY on this page. What the score means